查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1880601

家禽疫苗市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032 年）

Poultry Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 请询问到货日

价格

家禽疫苗市场成长推动因素

受家禽产品需求成长、传染病发病率上升以及家禽群健康管理意识增强的推动，全球家禽疫苗市场正经历显着增长。预计 2024 年市场规模将达到 12.7 亿美元，2025 年将达到 13.2 亿美元，到 2032 年将成长至 20.1 亿美元，在预测期内维持 6.13% 的稳定复合年增长率。由于严格的监管、先进的兽医基础设施以及主要行业参与者的存在，北美在2024年占了45.66%的市场占有率，成为市场主导者。

全球禽蛋和禽肉消费量的成长是市场成长的主要推动力。根据美国农业部预测，2024/2025年度美国鸡肉产量预计将达到2,134万吨，约占全球产量的21.0%。维持如此高的产量需要维持禽群健康，以确保食品安全、稳定供应和优质蛋白质来源。疫苗接种是预防禽流感、新城疫、马立克氏症和传染性支气管炎等疾病爆发的重要手段，能保障经济效益及禽类生产力。 2024年11月，Vaxxinova公司获得欧盟委员会对其新城疫病毒疫苗Vaxxon ND Clone的上市许可，显示该公司积极推广有效免疫接种。 市场推动因素与阻碍因素 家禽消费量的增长以及养殖户生物安全意识的提高，为该市场提供了强有力的支撑。疫苗接种不仅可以减少经济损失，还能提高家禽养殖场的整体健康状况和生产力。此外，Zoetis Services LLC、Merck & Co., Inc.和Boehringer Ingelheim International GmbH等主要公司正大力投资研发，以开发更有效、更经济的疫苗。这些策略举措进一步推动了市场扩张。 然而，全球家禽疫苗市场也面临挑战。疫苗失效和 "洩漏" 的风险限制了市场成长。家禽病原体（例如马立克氏症和禽流感）的高变异率会降低疫苗效力，并可能导致接种疫苗的禽群死亡率高达 10.0% 至 40.0%（印度报告）。此类案例加剧了农民的疑虑，并限制了疫苗的普及。

市场机会与趋势

政府主导的疫苗接种活动蕴藏着巨大的商机。例如，2025 年 4 月，印度畜牧和乳业部 (DAHD) 与家禽业合作进行高致病性禽流感 (HPAI) 疫苗接种活动，展现了政府为确保粮食安全而采取的积极举措。这些措施将有助于缩小免疫差距，尤其是在小农户群体中，并支持家禽疫苗市场的扩张。

一个值得关注的产业趋势是向卵内疫苗接种技术的转变。这项技术允许在孵化第18天将疫苗直接注入鸡蛋。这种方法能使雏鸡早期获得免疫力，减少人工成本，并消除传统皮下或眼部给药方式所带来的压力反应。领先企业正在加速研发卵内给药疫苗。例如，HIPRA于2022年10月在欧洲推出了卵内球虫病疫苗 "EVANOVO" 。

市场区隔分析

依技术分类

在2024年，灭活疫苗区隔市场占主导地位，这主要得益于疾病爆发的增加和对家禽食品安全需求的增长。 2025年2月，Zoetis Services LLC的禽流感疫苗（H5N2亚型）等关键产品的上市进一步巩固了这个区隔市场。

依疾病类型划分

2024年，病毒性疾病疫苗占了最大的市场占有率，这反映了禽流感、新城疫和马立克氏症日益增长的威胁。主要行业参与者正专注于病毒疫苗，以确保家禽群的生物安全。

依给药途径划分

由于其剂量控制精准且免疫反应强，肠外给药途径在2024年仍占主导地位。默克公司（Merck & Co. Inc.）的鸡用肌肉注射疫苗NOBILIS MULTRIVA REOm于2024年3月获得欧洲市场核准上市。

依通路划分

在政府积极政策和兽医广泛支持下，兽医诊所在2024年占了最大的市场占有率。例如，南非于2025年6月启动了针对高致病性禽流感（HPAI）的大规模疫苗接种运动。

区域展望

北美

在监管合规、强劲的家禽生产和研发资金的推动下，北美将成为2024年最大的区域市场（5.8亿美元）。 2025年4月，美国农业部（USDA）拨款1亿美元用于禽流感疫苗研究。

欧洲和亚太地区

预计到2025年，欧洲市场规模将达到3.6亿美元，这得益于对家禽产品需求的增长以及旨在维护家禽群健康的各项举措。预计到2025年，亚太地区市场规模将达到1.7亿美元，成为全球第三大市场，主要得益于家禽产量的增加和人们健康意识的提高。

拉丁美洲、中东和非洲

预计到2025年，拉丁美洲和中东/非洲地区的市场规模将分别温和成长1.1亿美元和6,000万美元，主要得益于政府的宣传活动和医疗保健政策。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势
  • 市场挑战

第四章：主要发现

  • 主要国家和地区家禽疾病概述（2024 年）
  • 主要国家和地区监管状况（2024 年）
  • 家禽疾病疫苗接种概述
  • 主要公司新技术应用
  • 主要产业趋势（併购、合作、等等）

第五章：全球家禽疫苗市场分析、洞察与预测（2019-2032）

  • 市场分析、洞察与预测 - 依技术分类
    • 灭活​​疫苗
    • 减毒活疫苗
    • 重组疫苗
    • 其他
  • 市场分析、洞察与预测 - 依疾病类型分类
    • 病毒性疾病
      • 禽流感
      • 新城疫
      • 马立克氏症
      • 其他
    • 细菌性疾病
      • 沙门氏菌病
      • 支原体病
      • 其他
    • 寄生虫疾病
  • 市场分析、洞察与预测 - 依给药途径
    • 肠外给药
    • 鼻腔给药
    • 其他
  • 市场分析、洞察与预测 - 依销售管道
    • 兽医院
    • 兽医诊所
    • 药局
    • 其他
  • 市场分析、洞察与预测 - 依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美家禽疫苗市场分析、洞察与预测（2019-2032）

  • 依国家/地区
    • 美国各州
    • 加拿大

第七章 欧洲家禽疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章 亚太地区家禽疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲家禽疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章：中东与非洲家禽疫苗市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲国家

第十一章：竞争分析

  • 全球市占率分析（2024）
  • 公司简介
  • 礼来动保
  • 勃林格殷格翰国际股份有限公司
  • 维克
  • 默克有限公司
  • 硕腾服务有限公司
  • 塞瓦酒
  • Bioveta, a.s.
  • 印度免疫学有限公司
  • 海普拉
Product Code: FBI113875

Growth Factors of poultry vaccines Market

The global poultry vaccines market is witnessing significant growth, driven by increasing demand for poultry products, rising incidence of infectious diseases, and greater awareness of flock health management. The market size was valued at USD 1.27 billion in 2024, is projected to reach USD 1.32 billion in 2025, and is expected to grow to USD 2.01 billion by 2032, representing a steady CAGR of 6.13% during the forecast period. North America dominated the market with a 45.66% share in 2024, owing to stringent regulations, advanced veterinary infrastructure, and the presence of major industry players.

The growing consumption of poultry eggs and meat worldwide is the primary driver for market expansion. According to the U.S. Department of Agriculture, 21.34 million metric tons of chicken meat were produced in 2024/2025 in the U.S., accounting for approximately 21.0% of global production. Such high production rates necessitate maintaining disease-free flocks to ensure food security, consistent supply, and high-quality protein. Vaccination serves as a critical tool to prevent outbreaks of diseases such as avian influenza, Newcastle disease, Marek's disease, and infectious bronchitis, thereby protecting economic interests and poultry productivity. In November 2024, Vaxxinova received marketing authorization from the European Commission for Vaxxon ND Clone, a vaccine targeting Newcastle Disease virus, exemplifying the active push for effective immunization.

Market Drivers and Restraints

The market is strongly supported by rising poultry consumption and increasing awareness of biosecurity practices among farmers. Vaccinations not only reduce economic losses but also enhance the overall health and productivity of poultry farms. Additionally, key players such as Zoetis Services LLC, Merck & Co., Inc., and Boehringer Ingelheim International GmbH are investing heavily in research and development to produce more effective and affordable vaccines. These strategic initiatives further reinforce market expansion.

However, the global poultry vaccines market faces challenges. Vaccine failures and "leaky" vaccine risks pose a restraint to growth. High mutation rates in poultry pathogens, such as Marek's disease and avian influenza, can reduce vaccine efficacy, leading to mortality rates ranging between 10.0% and 40.0% in vaccinated flocks, as reported in India. Such occurrences increase farmer skepticism and limit vaccine adoption.

Market Opportunities and Trends

Government-led vaccination campaigns present lucrative opportunities. For instance, in April 2025, India's Department of Animal Husbandry & Dairying (DAHD) collaborated with the poultry industry to administer vaccines against Highly Pathogenic Avian Influenza (HPAI), highlighting proactive measures to ensure food security. Such initiatives help bridge immunity gaps, particularly among small-scale farmers, and support the expansion of the poultry vaccines market.

A prominent industry trend is the shift toward in-ovo vaccination technology, which allows vaccines to be administered directly into eggs at day 18 of incubation. This approach provides chicks with early immunity, reduces labor, and eliminates stress associated with traditional subcutaneous or ocular methods. Key players are increasingly launching vaccines designed for in-ovo application. For example, HIPRA introduced EVANOVO in Europe in October 2022, a vaccine targeting coccidiosis for in-ovo administration.

Segmentation Analysis

By Technology

The inactivated vaccines segment dominated the market in 2024, driven by rising disease outbreaks and growing demand for poultry food security. Key launches, such as Zoetis Services LLC's Avian Influenza Vaccine, H5N2 subtype, in February 2025, continue to bolster the segment.

By Disease Type

The viral diseases segment accounted for the largest share in 2024, reflecting increasing threats from avian influenza, Newcastle disease, and Marek's disease. Major industry players are focusing on viral vaccines to ensure flock biosecurity.

By Route of Administration

The parenteral segment remained dominant in 2024 due to precise dose delivery and stronger immune responses. Merck & Co., Inc., received European marketing authorization in March 2024 for NOBILIS MULTRIVA REOm, an intramuscular vaccine for chickens.

By Distribution Channel

Veterinary hospitals held the leading market share in 2024, supported by active government initiatives and widespread veterinary outreach. For instance, South Africa launched a mass vaccination campaign in June 2025 targeting HPAI.

Regional Outlook

North America

The largest regional market in 2024 with USD 0.58 billion, driven by regulatory compliance, strong poultry production, and research funding. The USDA allocated USD 100 million in April 2025 for avian influenza vaccine research.

Europe & Asia Pacific

Europe is expected to reach USD 0.36 billion in 2025, supported by increasing poultry product demand and flock health initiatives. Asia Pacific is projected to attain USD 0.17 billion in 2025, ranking third globally due to expanding poultry production and rising health awareness.

Latin America & Middle East/Africa

Latin America and Middle East/Africa are expected to grow moderately, reaching USD 0.11 billion and USD 0.06 billion, respectively, in 2025, supported by government campaigns and healthcare initiatives.

Competitive Landscape

The market is semi-fragmented, with Zoetis, Merck & Co., Boehringer Ingelheim, Elanco, Ceva, HIPRA, and others actively pursuing strategic collaborations, new product launches, and geographic expansion. Notable developments include Bioveta's launch of an inactivated bacterial vaccine in July 2025 and Virbac's acquisition of Globion in India in October 2023.

With projected growth to USD 2.01 billion by 2032, the global poultry vaccines market is poised for expansion, driven by rising protein demand, technological innovations, government support, and increasing focus on flock health and biosecurity.

Segmentation By Technology

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Disease Type

  • Viral Diseases
    • Avian Influenza
    • Newcastle Disease
    • Marek's Disease
    • Others
  • Bacterial Diseases
    • Salmonellosis
    • Mycoplasmosis
    • Others
  • Parasitic Diseases

By Route of Administration

  • Parenteral
  • Intranasal
  • Others

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country)
    • U.S.
    • Canada
  • Europe (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Technology, Disease Type, Route of Administration, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
  • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Overview of Poultry Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Poultry Diseases
  • 4.4. New Technology Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)

5. Global Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Technology
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Disease Type
    • 5.2.1. Viral Diseases
      • 5.2.1.1. Avian Influenza
      • 5.2.1.2. Newcastle Disease
      • 5.2.1.3. Marek's Disease
      • 5.2.1.4. Others
    • 5.2.2. Bacterial Diseases
      • 5.2.2.1. Salmonellosis
      • 5.2.2.2. Mycoplasmosis
      • 5.2.2.3. Others
    • 5.2.3. Parasitic Diseases
  • 5.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.3.1. Parenteral
    • 5.3.2. Intranasal
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Veterinary Hospitals
    • 5.4.2. Veterinary Clinics
    • 5.4.3. Pharmacies & Drug Stores
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Technology
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Disease Type
    • 6.2.1. Poultry Influenza
    • 6.2.2. Lyme Disease
    • 6.2.3. Rabies
    • 6.2.4. Leptospirosis
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.3.1. Oral
    • 6.3.2. Parenteral
    • 6.3.3. Intranasal
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Veterinary Hospitals
    • 6.4.2. Veterinary Clinics
    • 6.4.3. Pharmacies & Drug Stores
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Technology
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Disease Type
    • 7.2.1. Viral Diseases
      • 7.2.1.1. Avian Influenza
      • 7.2.1.2. Newcastle Disease
      • 7.2.1.3. Marek's Disease
      • 7.2.1.4. Others
    • 7.2.2. Bacterial Diseases
      • 7.2.2.1. Salmonellosis
      • 7.2.2.2. Mycoplasmosis
      • 7.2.2.3. Others
    • 7.2.3. Parasitic Diseases
  • 7.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.3.1. Parenteral
    • 7.3.2. Intranasal
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Veterinary Hospitals
    • 7.4.2. Veterinary Clinics
    • 7.4.3. Pharmacies & Drug Stores
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Technology
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Disease Type
    • 8.2.1. Viral Diseases
      • 8.2.1.1. Avian Influenza
      • 8.2.1.2. Newcastle Disease
      • 8.2.1.3. Marek's Disease
      • 8.2.1.4. Others
    • 8.2.2. Bacterial Diseases
      • 8.2.2.1. Salmonellosis
      • 8.2.2.2. Mycoplasmosis
      • 8.2.2.3. Others
    • 8.2.3. Parasitic Diseases
  • 8.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.3.1. Parenteral
    • 8.3.2. Intranasal
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Veterinary Hospitals
    • 8.4.2. Veterinary Clinics
    • 8.4.3. Pharmacies & Drug Stores
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Technology
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Disease Type
    • 9.2.1. Viral Diseases
      • 9.2.1.1. Avian Influenza
      • 9.2.1.2. Newcastle Disease
      • 9.2.1.3. Marek's Disease
      • 9.2.1.4. Others
    • 9.2.2. Bacterial Diseases
      • 9.2.2.1. Salmonellosis
      • 9.2.2.2. Mycoplasmosis
      • 9.2.2.3. Others
    • 9.2.3. Parasitic Diseases
  • 9.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.3.1. Parenteral
    • 9.3.2. Intranasal
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Veterinary Hospitals
    • 9.4.2. Veterinary Clinics
    • 9.4.3. Pharmacies & Drug Stores
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Poultry Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Technology
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Disease Type
    • 10.2.1. Viral Diseases
      • 10.2.1.1. Avian Influenza
      • 10.2.1.2. Newcastle Disease
      • 10.2.1.3. Marek's Disease
      • 10.2.1.4. Others
    • 10.2.2. Bacterial Diseases
      • 10.2.2.1. Salmonellosis
      • 10.2.2.2. Mycoplasmosis
      • 10.2.2.3. Others
    • 10.2.3. Parasitic Diseases
  • 10.3. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.3.1. Parenteral
    • 10.3.2. Intranasal
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.4.1. Veterinary Hospitals
    • 10.4.2. Veterinary Clinics
    • 10.4.3. Pharmacies & Drug Stores
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles (Overview, Technology, SWOT analysis, Recent developments, strategies, financials (based on availability)
    • 11.2.1. Elanco
    • 11.2.2. Boehringer Ingelheim International GmbH
    • 11.2.3. Virbac
    • 11.2.4. Merck & Co., Inc.
    • 11.2.5. Zoetis Services LLC
    • 11.2.6. Ceva
    • 11.2.7. Bioveta, a.s.
    • 11.2.8. Indian Immunologicals Ltd.
    • 11.2.9. HIPRA

List of Tables

  • Table 1: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 2: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 3: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 4: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 5: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 6: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 7: Global Poultry Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 8: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 9: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 10: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 11: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 12: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 13: North America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 14: North America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 15: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 16: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 17: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 18: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 19: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 20: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 21: Europe Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 22: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 23: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 24: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 25: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 26: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 27: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 28: Asia Pacific Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 29: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 30: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 31: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 32: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 33: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 34: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 35: Latin America Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 36: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
  • Table 37: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
  • Table 38: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Viral Diseases, 2019-2032
  • Table 39: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Bacterial Diseases, 2019-2032
  • Table 40: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 41: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 42: Middle East & Africa Poultry Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Poultry Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Poultry Vaccines Market Value Share (%), by Technology, 2024 & 2032
  • Figure 3: Global Poultry Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
  • Figure 4: Global Poultry Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 5: Global Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 6: Global Poultry Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 7: North America Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 8: North America Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 9: North America Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 10: North America Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 11: North America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 12: North America Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 13: North America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 14: North America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 15: North America Poultry Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 16: North America Poultry Vaccines Market Value Share (%), By Country, 2024
  • Figure 17: Europe Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 18: Europe Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 19: Europe Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 20: Europe Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 21: Europe Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 22: Europe Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 23: Europe Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 24: Europe Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 25: Europe Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 26: Europe Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 27: Asia Pacific Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 28: Asia Pacific Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 29: Asia Pacific Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 30: Asia Pacific Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 31: Asia Pacific Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 32: Asia Pacific Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 33: Asia Pacific Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 34: Asia Pacific Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 35: Asia Pacific Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 36: Asia Pacific Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 37: Latin America Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 38: Latin America Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 39: Latin America Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 40: Latin America Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 41: Latin America Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 42: Latin America Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 43: Latin America Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 44: Latin America Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 45: Latin America Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 46: Latin America Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 47: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Technology, 2024 & 2032
  • Figure 48: Middle East & Africa Poultry Vaccines Market Value Share (%), by Technology, 2024
  • Figure 49: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
  • Figure 50: Middle East & Africa Poultry Vaccines Market Value Share (%), by Disease Type, 2024
  • Figure 51: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 52: Middle East & Africa Poultry Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 53: Middle East & Africa Poultry Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 54: Middle East & Africa Poultry Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 55: Middle East & Africa Poultry Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 56: Middle East & Africa Poultry Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 57: Global Poultry Vaccines Market Share (%), By Company, 2024